HRT Financial’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $630K | Buy |
40,773
+18,865
| +86% | +$291K | ﹤0.01% | 1268 |
|
2025
Q1 | $325K | Buy |
+21,908
| New | +$325K | ﹤0.01% | 1532 |
|
2024
Q2 | – | Sell |
-23,195
| Closed | -$322K | – | 2896 |
|
2024
Q1 | $322K | Buy |
+23,195
| New | +$322K | ﹤0.01% | 1434 |
|
2023
Q3 | – | Sell |
-59,627
| Closed | -$936K | – | 2812 |
|
2023
Q2 | $936K | Buy |
59,627
+24,186
| +68% | +$380K | 0.01% | 920 |
|
2023
Q1 | $584K | Buy |
+35,441
| New | +$584K | 0.01% | 1168 |
|
2021
Q2 | – | Sell |
-78,827
| Closed | -$1.44M | – | 3319 |
|
2021
Q1 | $1.44M | Buy |
+78,827
| New | +$1.44M | 0.01% | 701 |
|
2020
Q4 | – | Sell |
-21,662
| Closed | -$386K | – | 2362 |
|
2020
Q3 | $386K | Buy |
+21,662
| New | +$386K | 0.01% | 939 |
|
2019
Q3 | – | Sell |
-62,807
| Closed | -$1.11M | – | 1493 |
|
2019
Q2 | $1.11M | Buy |
62,807
+45,407
| +261% | +$803K | 0.07% | 241 |
|
2019
Q1 | $354K | Buy |
+17,400
| New | +$354K | 0.05% | 233 |
|